AMGN compared with IMVT: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

IMVTImmunovant, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only IMVT 4

ROIVRoivant Sciencessupplier

—Ypsomedunlistedsupplier

—Roivant Sciences GmbHunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

HanAll

unlistedsupplier

AMGNAmgen Inc

461.49· pre 448.53· delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

IMVTImmunovant, Inc.

28.44· pre 28.60· delayed

Pre-marketNov 6 '26delayed

Mkt cap$5.9BRevenue—Revenue—

Compare

Pre-marketNov 6 '26delayed

AMGNAmgen Inc

IMVTImmunovant, Inc.

461.49pre 448.53delayed

Price

28.44pre 28.60delayed

$249.0B

Mkt cap

$5.9B

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN461.49vsIMVT28.44Pre-marketNov 6 '26delayed